{"id":"NCT01534533","sponsor":"Peking University","briefTitle":"Effects of Lutein Supplementation on Subclinical Atherosclerosis","officialTitle":"The Effects of Lutein Supplementation on Subclinical Atherosclerosis","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2010-06","primaryCompletion":"2011-06","completion":"2012-06","firstPosted":"2012-02-16","resultsPosted":"2012-10-15","lastUpdate":"2013-07-22"},"enrollment":192,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Carotid Atherosclerosis","Carotid Intimal Medial Thickness 1"],"interventions":[{"type":"DIETARY_SUPPLEMENT","name":"Placebo","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"Lutein group","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"Combination group","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"Normal lutein control group","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Lutein group","type":"EXPERIMENTAL"},{"label":"Combination group","type":"EXPERIMENTAL"},{"label":"Normal lutein control group","type":"EXPERIMENTAL"}],"summary":"This study is to investigate the possible positive effects of lutein and lycopene supplementation on early atherosclerosis in Beijing.","primaryOutcome":{"measure":"Table 1 Study Specific Characteristic Part One","timeFrame":"at baseline","effectByArm":[{"arm":"Placebo (P Group)","deltaMin":69.8,"sd":null},{"arm":"Lutein Group (L Group)","deltaMin":59.8,"sd":null},{"arm":"Lutein and Lycopene Group (LL Group)","deltaMin":59.1,"sd":null},{"arm":"Normal Lutein Control Group (NL Group)","deltaMin":72.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":">0.05"}]},"eligibility":{"minAge":"45 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":1,"countries":["China"]},"refs":{"pmids":["21872250"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":40},"commonTop":[]}}